We invite you to review the full report to better understand the drivers of and barriers to treatment choice, initiation, and continuation, and the impact they can have on your brand’s patient share.
Through our enterprise platform, OptimizeRx can help reach multiple sclerosis patients and their care providers at every step of the journey from symptom presentation to maintaining recommended therapies.
OptimizeRx’s recently published report reveals valuable insights
for MS treatment manufacturers, including:
OptimizeRx Corporation (NASDAQ: OPRX) is the best-in-class health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through a proprietary point-of-care network, connectivity is facilitated via its integrated Therapy Initiation and Persistence Platform. This powerful digital healthcare solutions platform is transforming market and patient access with the life sciences market by unlocking:
OptimizeRx Corporation
+1 (248) 651-6568